None listed
Conditions
Interventions
Drug, Procedure/Surgery : Conventional drug treatment: Take Celebrex 100mg twice a day or 200mg once a day, Lyrica 75mg twice a day
Deep acupuncture point acupotomy therapy: Sterilized stainless steel
Sponsors
Catholic Kwandong University International St.Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Those who have been diagnosed with lumbosacral disc disorder (damage), spinal stenosis, or spondylosis accompanied by radiculopathy through radiological examination (MRI or CT) within 6 months before participating in the clinical trial. Patients who have symptoms related to lumbosacral neuropathy, such as radiating pain in the lower extremities, muscle weakness, or paresthesia, or who have been diagnosed with lumbosacral neuropathy through a physical examination. Patients with NRS4 or higher with back pain or lower extremity pain due to lumbosacral neuropathy.
Exclusion criteria
Exclusion criteria: Patients who have a history of spine surgery such as lumbosacral intrametal fixation or spinal fusion, or who have undergone spine surgery in the past but still experience pain related to the spine Patients who are judged by the research staff to require surgical treatment due to cauda equina syndrome or motor paralysis and neurological symptoms that are expected to be difficult to recover from conservative therapy Patients receiving active medication such as strong narcotic analgesics for the purpose of pain control Those who received oriental medicine treatment within 2 weeks before the start of the clinical trial baseline Those who show saliva hypersensitivity, metal allergy, severe atopy, skin sensitivity, etc. hemophilia patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oswestry Disability Index, Numeral rating scale, The 5-level European Quality of Life 5 Dimension, McGill pain Questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Direct medical expenses, direct non-medical expenses, productivity loss costs | — |
Countries
Korea, Republic of
Contacts
Public ContactMinju Kim
Daejeon Korean Medicine Hospital of Daejeon University
Outcome results
None listed